glp 1 drugs anti inflammatory GLP-1 calm inflammation beyond diabetes and weight loss Central glucagon-like peptide 1 receptor
Description
Only 5% started exercising for the first time while on GLP-1 medication, and 12% are doing so less frequently than before
These medications, which were initially developed to treat diabetes, mimic a hormone that makes us feel fuller and eat less
JAMA 313 , 2263 (2015)
First, evaluate the dosing frequency
By late 2025, an estimated 3040 million Americans (~1012.5% of adults) were taking GLP-1 drugs ( [1] ) ( [2] )
